Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference




Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics (Garuda), a company creating off-the-shelf, blood stem cell therapies, today announced that Dhvanit Shah, Ph.D., Co-founder, President and Chief Executive Officer, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10 at 9:30 am PT.


Garuda’s breakthrough platform and manufacturing technology for making Hematopoietic Stem Cells (gHSCs) offers the potential to provide curative, off-the-shelf treatments for patients around the world.

About Garuda Therapeutics

Garuda Therapeutics seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible and transgene-free blood stem cell therapies. Like bone marrow transplants, our technology could provide potentially curative therapies for more than 120 diseases. https://garudatx.com/

Contacts

Media
MacDougall Advisors
Megan Prock McGrath

mmcgrath@macdougall.bio
(781) 235-3060